IRIS
HEFFLER, Enrico Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.497
AS - Asia 4.659
EU - Europa 2.275
SA - Sud America 1.492
AF - Africa 359
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 18.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.292
SG - Singapore 2.795
BR - Brasile 1.273
CN - Cina 784
FI - Finlandia 399
IT - Italia 341
IE - Irlanda 314
DE - Germania 304
VN - Vietnam 300
NG - Nigeria 262
FR - Francia 185
HK - Hong Kong 157
GB - Regno Unito 141
NL - Olanda 141
IN - India 120
CA - Canada 111
SE - Svezia 87
AR - Argentina 85
MX - Messico 71
TR - Turchia 64
BD - Bangladesh 59
RU - Federazione Russa 59
ID - Indonesia 48
TW - Taiwan 47
ZA - Sudafrica 42
BE - Belgio 41
EC - Ecuador 41
JP - Giappone 41
KR - Corea 41
AU - Australia 39
CZ - Repubblica Ceca 37
ES - Italia 37
IQ - Iraq 35
PL - Polonia 30
UA - Ucraina 28
CH - Svizzera 26
CO - Colombia 26
IL - Israele 24
PK - Pakistan 22
AT - Austria 19
VE - Venezuela 19
CL - Cile 17
MA - Marocco 14
PY - Paraguay 14
UZ - Uzbekistan 14
RO - Romania 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 12
EG - Egitto 11
MY - Malesia 11
AZ - Azerbaigian 10
JO - Giordania 10
LT - Lituania 9
UY - Uruguay 9
DZ - Algeria 8
PT - Portogallo 8
AL - Albania 7
IR - Iran 7
NO - Norvegia 7
PE - Perù 7
KE - Kenya 6
KZ - Kazakistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
NP - Nepal 5
NZ - Nuova Zelanda 5
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
DO - Repubblica Dominicana 3
GM - Gambi 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
TH - Thailandia 3
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
HR - Croazia 2
JM - Giamaica 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BY - Bielorussia 1
Totale 18.317
Salva come PNG Salva come JPEG
Città #
Chandler 1.322
Wilmington 1.289
Dallas 799
Singapore 784
The Dalles 717
San Mateo 482
Shanghai 450
Ann Arbor 415
Helsinki 394
Ashburn 294
Dublin 294
Benin City 259
Boardman 257
Lawrence 234
Princeton 234
Leawood 221
New York 194
Beijing 140
Hong Kong 136
Fairfield 124
Paris 119
Ho Chi Minh City 116
São Paulo 109
Woodbridge 107
Amsterdam 99
Los Angeles 79
Hanoi 67
Santa Clara 67
Toronto 65
London 63
Seattle 52
Milan 49
Munich 40
Rio de Janeiro 37
San Diego 35
Redwood City 34
Belo Horizonte 33
Brussels 31
Council Bluffs 31
Columbus 30
Kocaeli 30
Norwalk 30
Menlo Park 28
Naples 27
Pune 26
Phoenix 25
Curitiba 24
Warsaw 23
Brasília 22
Mexico City 21
Monmouth Junction 21
Tokyo 21
Boston 20
Brno 20
Johannesburg 20
Newark 20
Campinas 19
Stockholm 19
Brooklyn 17
Houston 17
Guayaquil 16
Porto Alegre 16
Falls Church 15
Haiphong 15
Salvador 15
San Francisco 15
Buffalo 14
Dongguan 14
Jakarta 14
Montreal 14
Mumbai 14
Nuremberg 14
Baghdad 13
Chicago 13
Guarulhos 13
Denver 12
Goiânia 12
Hyderabad 12
Rome 12
Atlanta 11
Melbourne 11
Philadelphia 11
Tashkent 11
Amman 10
Baku 10
Da Nang 10
Dhaka 10
Moscow 10
Quito 10
Redmond 10
Reston 10
Chennai 9
Istanbul 9
Prague 9
Secaucus 9
Shenzhen 9
Zhengzhou 9
Asunción 8
Cambridge 8
Charlotte 8
Totale 11.217
Salva come PNG Salva come JPEG
Nome #
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 629
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 348
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 291
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey 181
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 142
A critical appraisal on AIT in childhood asthma. 126
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 126
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 119
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 117
Research needs in allergy: an EAACI position paper, in collaboration with EFA 116
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 108
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 108
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 107
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 107
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 107
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 105
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 103
An academic allergy unit during COVID-19 pandemic in Italy. 102
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 100
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 98
Allergy in severe asthma. 98
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 96
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 96
Acute urticaria presenting in the emergency room of a general hospital 93
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 93
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 92
Allergy in internet 92
Acute asthma management during SARS-CoV2-pandemic 2020 90
Adherence issues related to sublingual immunotherapy as perceived by allergists. 88
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 85
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 84
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 82
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 82
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 81
Nasal cytology: Methodology with application to clinical practice and research. 81
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 81
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 78
Unexplained chronic cough and vitamin B-12 deficiency. 77
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 77
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 76
Anaphylaxis after a horse bite 76
Level of exhaled nitric oxide during human anaphylaxis 75
Asthma from immune pathogenesis to precision medicine 75
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 75
The Severe Asthma Network in Italy: Findings and Perspectives 74
Strategies to reduce corticosteroid-related adverse events in asthma 74
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 74
Unexpected visitor: “hidden” food allergens 73
Interleukin-5 in the Pathophysiology of Severe Asthma 73
Treatable traits in chronic rhinosinusitis with nasal polyps 73
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 73
Alpha1-antitrypsin deficiency and asthma 73
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 72
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 72
Microarray Immunodiagnostics for Aeroallergens 72
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 71
Exhaled nitric oxide in asthma. 71
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 71
Determinants of exhaled nitric oxide in chronic rhinosinusitis 70
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 70
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 70
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 69
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 69
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 68
One year of mepolizumab. Efficacy and safety in real-life in Italy 68
Bronchodilator response as a marker of poor asthma control 67
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 67
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 67
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 67
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 67
Eosinophils Target Therapy for Severe Asthma: Critical Points 67
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 67
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 67
Minimal clinically important difference for asthma endpoints: an expert consensus report 67
TNF-alpha: a promising therapeutic target for asthma? 66
Nasal nitric oxide in patients with inherited retinal dystrophies. 66
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 66
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 65
Gene Environment Interactions in Respiratory Diseases – Protocol, Standard Operative Procedures and Questionnaires 65
Adult Severe Asthma Registries: A Global and Growing Inventory 64
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 64
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 64
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 64
Escaping the trap of allergic rhinitis. 63
Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough 63
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 62
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 62
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 62
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 61
Thunderstorm-related asthma epidemic owing to Olea Europaea pollen sensitization. 61
Current insights in allergen immunotherapy. 61
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study 61
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 61
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 61
New drugs in early-stage clinical trials for allergic rhinitis 61
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 61
Basophil activation test: a reliable biomarker for allergen immunotherapy? 60
Omalizumab Treatment of Vernal Keratoconjunctivitis 60
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 60
Exhaled nitric oxide as a marker of diseases 60
Totale 8.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.416 0 0 0 0 0 781 345 228 467 311 43 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/20254.141 128 105 78 106 156 385 229 392 643 925 467 527
2025/20264.580 1.378 623 992 1.086 317 184 0 0 0 0 0 0
Totale 18.590